Our work on changes in dopaminergic, glutamatergic, and cholinergic behavioral pharmacology in Fmr1-null mice has been accepted for publication in PLoS ONE. Eric Fish (formerly of the Malanga Lab, now in the Sulik Lab) and Michael Krouse (formerly of the Malanga Lab, now a medical student at VCU) were first and second authors, respectively. Sierra Stringfield (Robinson Lab), Jeff DiBerto (Malanga Lab), and Elliott Robinson (Malanga Lab) also contributed. This work was made possible by funding from Autism Speaks.

Comments are closed.